← FDA Drug Approvals (Drugs@FDA)
ESTRADIOL AND NORETHINDRONE ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2017-02-10
Drug application
- FDA Application #
ANDA207261- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESTRADIOL AND NORETHINDRONE ACETATE
- Generic name
- ESTRADIOL AND NORETHINDRONE ACETATE
- Active ingredients
- ESTRADIOL; NORETHINDRONE ACETATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- XIROMED
- Manufacturer
- Xiromed LLC
- First approval
- 2017-02-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown